These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35998828)

  • 1. Strategies and progresses for enhancing targeted antibiotic delivery.
    Nazli A; He DL; Liao D; Khan MZI; Huang C; He Y
    Adv Drug Deliv Rev; 2022 Oct; 189():114502. PubMed ID: 35998828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimuli-sensitive drug delivery systems for site-specific antibiotic release.
    Nazir F; Tabish TA; Tariq F; Iftikhar S; Wasim R; Shahnaz G
    Drug Discov Today; 2022 Jun; 27(6):1698-1705. PubMed ID: 35219858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
    Luo C; Sun J; Sun B; He Z
    Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoantibiotics: A Novel Rational Approach to Antibiotic Resistant Infections.
    Engin AB; Engin A
    Curr Drug Metab; 2019; 20(9):720-741. PubMed ID: 31385767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades.
    Devnarain N; Osman N; Fasiku VO; Makhathini S; Salih M; Ibrahim UH; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1664. PubMed ID: 32808486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent updates in utilizing prodrugs in drug delivery (2013-2015).
    Amly W; Karaman R
    Expert Opin Drug Deliv; 2016; 13(4):571-91. PubMed ID: 26785610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug delivery systems designed to overcome antimicrobial resistance.
    Pham TN; Loupias P; Dassonville-Klimpt A; Sonnet P
    Med Res Rev; 2019 Nov; 39(6):2343-2396. PubMed ID: 31004359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in 'Trojan horse' strategies in antibiotic delivery systems.
    Dassonville-Klimpt A; Sonnet P
    Future Med Chem; 2020 Jun; 12(11):983-986. PubMed ID: 32270702
    [No Abstract]   [Full Text] [Related]  

  • 9. Prodrugs in combination with nanocarriers as a strategy for promoting antitumoral efficiency.
    Lin MH; Hung CF; Hsu CY; Lin ZC; Fang JY
    Future Med Chem; 2019 Aug; 11(16):2131-2150. PubMed ID: 31538520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prodrug approaches for the development of a long-acting drug delivery systems.
    Chien ST; Suydam IT; Woodrow KA
    Adv Drug Deliv Rev; 2023 Jul; 198():114860. PubMed ID: 37160248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering hybrid nanosystems for efficient and targeted delivery against bacterial infections.
    Elhassan E; Devnarain N; Mohammed M; Govender T; Omolo CA
    J Control Release; 2022 Nov; 351():598-622. PubMed ID: 36183972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is drug release necessary for antimicrobial activity of siderophore-drug conjugates? Syntheses and biological studies of the naturally occurring salmycin "Trojan Horse" antibiotics and synthetic desferridanoxamine-antibiotic conjugates.
    Wencewicz TA; Möllmann U; Long TE; Miller MJ
    Biometals; 2009 Aug; 22(4):633-48. PubMed ID: 19221879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoengineered drug delivery systems for enhancing antibiotic therapy.
    Kalhapure RS; Suleman N; Mocktar C; Seedat N; Govender T
    J Pharm Sci; 2015 Mar; 104(3):872-905. PubMed ID: 25546108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles as delivery carriers for anticancer prodrugs.
    Fang JY; Al-Suwayeh SA
    Expert Opin Drug Deliv; 2012 Jun; 9(6):657-69. PubMed ID: 22507134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signed, Sealed, Delivered: Conjugate and Prodrug Strategies as Targeted Delivery Vectors for Antibiotics.
    Cheng AV; Wuest WM
    ACS Infect Dis; 2019 Jun; 5(6):816-828. PubMed ID: 30969100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoliposome-based antibacterial drug delivery.
    Hallaj-Nezhadi S; Hassan M
    Drug Deliv; 2015; 22(5):581-9. PubMed ID: 24313827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoscale aggregation of doxorubicin-short peptide conjugates for enzyme-responsive delivery with various MOF carriers: In-silico steps towards smart cancer chemotherapy.
    Dahri M; Abolmaali SS; Maleki R; Najafi H; Abedanzadeh M; Tamaddon AM
    Comput Biol Med; 2022 May; 144():105386. PubMed ID: 35272116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ-restricted delivery through stimuli-responsive nanocarriers for lung cancer therapy.
    Dinakar YH; Karole A; Parvez S; Jain V; Mudavath SL
    Life Sci; 2022 Dec; 310():121133. PubMed ID: 36306866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Siderophore-Antibiotic Conjugate Design: New Drugs for Bad Bugs?
    Negash KH; Norris JKS; Hodgkinson JT
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31514464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.